ABSTRACT
Uma égua SRD, com 20 anos de idade, foi encaminhada ao hospital veterinário com histórico de emagrecimento, perda de apetite e aumento de volume na região peitoral e no pescoço. Aos exames físico e laboratorial, constatou-se que o animal apresentava taquicardia, taquipneia, hiperproteinemia, hiperfibrinogenemia e hipoalbuminemia. À auscultação cardíaca, os sons das válvulas pulmonar e aórtica não foram audíveis. Realizaram-se as avaliações eletrocardiográfica e ecodopplercardiográfica transtorácica bilateral, nas quais se observaram presença de efusão pleural e deslocamento caudal do coração. Na varredura ultrassonográfica ao redor do coração, constatou-se a presença de uma massa na base do coração. Para tentar amenizar o quadro respiratório, foi realizada drenagem torácica. A efusão pleural apresentava característica serossanguinolenta, com padrão citológico inflamatório. Algumas horas após retornar a baia, o animal veio a óbito. Realizou-se a necropsia, na qual pôde ser observada a presença da massa posicionada ao redor do tronco braquiocefálico. Na análise histopatológica, diagnosticou-se o linfoma difuso de células pequenas e médias.(AU)
A 20-year-old mixed breed mare was referred to the veterinary hospital with history of weight loss, loss of appetite, and swelling of the chest and neck. On physical exam the patient was in tachycardia and tachypnea and laboratory results indicated hyperproteinemia, hyperfibrinogenemia and hypoalbuminemia. On cardiac auscultation, the pulmonary and aortic valves sounds were not audible. Presence of pleural effusion and heart caudal displacement were identified on electrocardiographic and Doppler echocardiography evaluation and a mass at the base of the heart was oberved through ultrasound scanning around the heart. To alleviate the respiratory condition, thoracic drainage was performed. The pleural effusion presented characteristic serosanguineous with cytologic inflammatory. After returning to stall, the animal died. In necropsy, the presence of a mass positioned around the brachiocephalic trunk was identified and histopathology results were compatible with diffuse small and medium cell lymphoma.(AU)
Subject(s)
Animals , Horses/abnormalities , Lymphoma/classification , Neoplasms/classificationABSTRACT
El neuroblastoma es el tumor sólido pediátrico extracraneal más frecuente, que representa un 5,6% según el Registro On-copediátrico Hospitalario Argentino. Se requieren, para su diagnóstico, varios métodos complementarios (radiológicos, biológicos y bioquímicos), entre los que la citometría de flujo multiparamétrica (CFM) surge con un potencial rol, aún no explorado. La CFM es una metodología que permite obtener información sobre el tamano, la complejidad y la expresión antigénica de la célula mediante el uso de un láser y anticuerpos monoclonales fluorescentes. Existe un creciente número de trabajos en la literatura que dan cuenta de la relevancia de la aplicación de la CFM en el diagnóstico y seguimiento de tumores sólidos. El objetivo de esta presentación es destacar el rol fundamental que tuvo la CFM en el caso de una paciente con neuroblastoma, en la cual un diagnóstico precoz permitió administrar rápidamente un adecuado tratamiento inicial.
Neuroblastoma is the most frequent extracranial solid tumor in childhood, representing 5.6% according to the "Registro Oncopediátrico Hospitalario Argentino". For its diagnosis, several complementary methods (radiological, biological and biochemical) are required, and Multi-parametric Flow Cytometry (MFC) arises as a potential diagnostic method, despite not having been so far extensively explored. MFC is a method that allows to obtain several information about size, internal complexity and antigenic expression by the use of a laser and fluorescent monoclonal antibodies. There is an increasing number of reports in the literature which reveal the importance of using MFC for diagnosis and monitoring of solid tumors. The aim in this presentation is to highlight the fundamental role that MFC had in the case of a patient affected by neuroblastoma, in whom an early diagnosis using this methodology allowed prompt administration of adequate treatment.
Subject(s)
Humans , Female , Infant , Flow Cytometry , Neuroblastoma/diagnosisABSTRACT
Objective To explore the efficiency and prognosis of hematological malignancies treated by haploidentical hematopoietic stem cell transplantation.Methods 70 patients who received haploidentical hematopoietic stem cell transplantation were analyzed retrospectively.According to tumor burden before transplantation,the patients were divided into three groups,the low tumor burden group,the mediate tumor burden group and the high tumor burden group.And then the effection of the tumor burden to survival was analyzed,and the engraftment,GVHD,infection,conditioning related toxicity,relapse and survival rate were also observed.Results The follow-up was terminated on January 1,2014.Follow-ups were performed for a median of 34.05 (7.4-83.6) months after transplantation.All patients achieved engraftments.The cumulative incidence of GVHD of grades 2-4 was 47.14 ％ (33/70) and that of grades 3-4 was 21.4 ％ (15/70).The chronic extensive GVHD was 20.0 ％ (14/70).The overall survival was 68.6 ％.Transplant-related mortality was 12.8 ％ and the relapse was 18.6 ％.The overall survivals in low tumor burden group,mediate tumor burden group,high tumor burden group were 91.67 ％,72.7 ％,33.3 ％ respectively.By SPSS 20.0,tumor burden was the high risk factor affecting the survival (low tumor group vs high tumor group,mediate tumor group vs high tumor group,low tumor group vs high tumor group,P =0.000,P =0.038,P =0.016).Conclusions Haploidentical hematopoietic stem cell transplantation in hematological malignancies is safe and effective.And for hematological malignancies with poor prognosis disease,it should be accepted the HSCT as soon as possible after remission in order to reduce the recurrence rate of malignancy.